Package 50090-1085-0

{"route": ["ORAL"], "spl_id": "fa8200b3-64ad-4ba4-a708-7a9b564d2ac8", "openfda": {"unii": ["43Y000U234"], "rxcui": ["744842", "744846"], "spl_set_id": ["7e659505-c902-4906-9461-1cc83e2236d2"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (50090-1085-0)", "package_ndc": "50090-1085-0", "marketing_start_date": "20141128"}], "brand_name": "ISENTRESS", "product_id": "50090-1085_fa8200b3-64ad-4ba4-a708-7a9b564d2ac8", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HIV Integrase Inhibitors [MoA]", "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]"], "product_ndc": "50090-1085", "generic_name": "RALTEGRAVIR", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ISENTRESS", "active_ingredients": [{"name": "RALTEGRAVIR POTASSIUM", "strength": "400 mg/1"}], "application_number": "NDA022145", "marketing_category": "NDA", "marketing_start_date": "20071012", "listing_expiration_date": "20261231"}